Page 243 - Read Online

Anti‑NMDA‑receptor encephalitis: case series and analysis of the Klingbeil C, Wandinger KP, Bogerts B, Stoecker W. Increased
effects of antibodies. Lancet Neurol 2008;7:1091‑8. prevalence of diverse N‑methyl‑D‑aspartate glutamate receptor
35. Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J. antibodies in patients with an initial diagnosis of schizophrenia:
Anti‑NMDA‑receptor encephalitis: a severe, multistage, specific relevance of IgG NR1a antibodies for distinction from
treatable disorder presenting with psychosis. J Neuroimmunol N‑methyl‑D‑aspartate glutamate receptor encephalitis. JAMA
2011;231:86‑91. Psychiatry 2013;70:271‑8.
36. Luca N, Daengsuwan T, Dalmau J, Jones K, deVeber G, 54. Maneta E, Garcia G. Psychiatric manifestations of anti‑NMDA
Kobayashi J, Laxer RM, Benseler SM. Anti‑N‑methyl‑D‑aspartate receptor encephalitis: neurobiological underpinnings and differential
receptor encephalitis: a newly recognized inflammatory brain disease diagnostic implications. Psychosomatics 2014;55:37‑44.
in children. Arthritis Rheum 2011;63:2516‑22. 55. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F,
37. Pruss H, Dalmau J, Harms L, Holtje M, Ahnert‑Hilger G, Borowski K, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV,
Stoecker W, Wandinger KP. Retrospective analysis of NMDA Amminger P, McGorry P, Malhi GS. Pathways underlying
receptor antibodies in encephalitis of unknown origin. Neurology neuroprogression in bipolar disorder: focus on inflammation,
2010;75:1735‑9. oxidative stress and neurotrophic factors. Neurosci Biobehav Rev
38. Barry H, Hardiman O, Healy DG, Keogan M, Moroney J, Molnar PP, 2011;35:804‑17.
Cotter DR, Murphy KC. Anti‑NMDA receptor encephalitis: an 56. Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB. Autoimmune
important differential diagnosis in psychosis. Br J Psychiatry diseases, bipolar disorder, and non‑affective psychosis. Bipolar
2011;199:508‑9. Disord 2010;12:638‑46.
39. Fawcett RG. Acute psychosis associated with anti‑NMDA‑receptor 57. Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J
antibodies and bilateral ovarian teratomas: a case report. J Clin Neurol Neurosurg Psychiatry 2012;83:495‑502.
Psychiatry 2010;71:504. 58. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C,
40. Reid DK, Clardy SL. Neurological picture. Anti‑NMDA‑receptor Kerr S, Culliford D, Perry VH. Systemic inflammation and disease
encephalitis: unusual presentation of an uncommon condition. progression in Alzheimer disease. Neurology 2009;73:768‑74.
J Neurol Neurosurg Psychiatry 2013;84:69‑70. 59. Ellis JA, Kemp AS, Ponsonby AL. Gene‑environment interaction in
41. Pillai SC, Gill D, Webster R, Howman‑Giles R, Dale RC. Cortical autoimmune disease. Expert Rev Mol Med 2014;16:e4.
hypometabolism demonstrated by PET in relapsing NMDA receptor 60. Cho JH, Gregersen PK. Genomics and the multifactorial nature of
encephalitis. Pediatr Neurol 2010;43:217‑20. human autoimmune disease. N Engl J Med 2011;365:1612‑23.
42. Corsellis JA, Goldberg GJ, Norton AR. “Limbic encephalitis” and 61. Perugi G, Quaranta G, Belletti S, Casalini F, Mosti N, Toni C,
its association with carcinoma. Brain 1968;91:481‑96. DellOsso L. General medical conditions in 347 bipolar disorder
43. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, patients: clinical correlates of metabolic and autoimmune‑allergic
Schott JM, Armstrong RJ, Zagami AS, Bleasel A, Somerville ER, diseases. J Affect Disord 2015;170C:95‑103.
Smith SM, Vincent A. Faciobrachial dystonic seizures precede Lgi1 62. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology
antibody limbic encephalitis. Ann Neurol 2011;69:892‑900. and estimated population burden of selected autoimmune
44. Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. diseases in the United States. Clin Immunol Immunopathol
Clinical, magnetic resonance imaging, and electroencephalographic 1997;84:223‑43.
findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 63. de Monchy JG, Demoly P, Akdis CA, Cardona V, Papadopoulos NG,
2003;78:1363‑8. Schmid‑Grendelmeier P, Gayraud J. Allergology in Europe, the
45. Irani S, Lang B. Autoantibody‑mediated disorders of the central blueprint. Allergy 2013;68:1211‑8.
nervous system. Autoimmunity 2008;41:55‑65. 64. Brydon L, Walker C, Wawrzyniak A, Whitehead D, Okamura H,
46. Prosser HM, Gill CH, Hirst WD, Grau E, Robbins M, Calver A, Yajima J, Tsuda A, Steptoe A. Synergistic effects of psychological and
Soffin EM, Farmer CE, Lanneau C, Gray J, Schenck E, immune stressors on inflammatory cytokine and sickness responses
Warmerdam BS, Clapham C, Reavill C, Rogers DC, Stean T, in humans. Brain Behav Immun 2009;23:217‑24.
Upton N, Humphreys K, Randall A, Geppert M, Davies CH, 65. Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO,
Pangalos MN. Epileptogenesis and enhanced prepulse inhibition Mortensen PB. Autoimmune diseases and severe infections as risk
in GABA (B1)‑deficient mice. Mol Cell Neurosci 2001;17:1059‑70. factors for schizophrenia: a 30‑year population‑based register study.
47. Kawamata J, Ikeda A, Fujita Y, Usui K, Shimohama S, Takahashi R. Am J Psychiatry 2011;168:1303‑10.
Mutations in LGI1 gene in Japanese families with autosomal 66. Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E,
dominant lateral temporal lobe epilepsy: the first report from Asian Mortensen PB. Association of schizophrenia and autoimmune
families. Epilepsia 2010;51:690‑3. diseases: linkage of Danish national registers. Am J Psychiatry
48. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. 2006;163:521‑8.
Paraneoplastic limbic encephalitis: neurological symptoms, 67. Dalman C, Allebeck P, Gunnell D, Harrison G, Kristensson K,
immunological findings and tumour association in 50 patients. Brain Lewis G, Lofving S, Rasmussen F, Wicks S, Karlsson H. Infections
2000;123 (Pt 7):1481‑94. in the CNS during childhood and the risk of subsequent psychotic
49. Daniel SE, Love S, Scaravilli F, Harding AE. Encephalomyeloneuropathy illness: a cohort study of more than one million Swedish subjects.
in the absence of a detectable neoplasm. Clinical and postmortem Am J Psychiatry 2008;165:59‑65.
findings in three cases. Acta Neuropathol 1985;66:311‑7. 68. Yolken RH, Torrey EF. Are some cases of psychosis caused by
50. Barber PA, Anderson NE, Vincent A. Morvan’s syndrome microbial agents? A review of the evidence. Mol Psychiatry
associated with voltage‑gated K+ channel antibodies. Neurology 2008;13:470‑9.
2000;54:771‑2. 69. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW.
51. Peery HE, Day GS, Dunn S, Fritzler MJ, Pruss H, De Souza C, From inflammation to sickness and depression: when the immune
Doja A, Mossman K, Resch L, Xia C, Sakic B, Belbeck L, Foster WG. system subjugates the brain. Nat Rev Neurosci 2008;9:46‑56.
Anti‑NMDA receptor encephalitis. The disorder, the diagnosis and 70. Weiss JM, Stout JC, Aaron MF, Quan N, Owens MJ, Butler PD,
the immunobiology. Autoimmun Rev 2012;11:863‑72. Nemeroff CB. Depression and anxiety: role of the locus
52. Choe CU, Karamatskos E, Schattling B, Leypoldt F, Liuzzi G, coeruleus and corticotropin‑releasing factor. Brain Res Bull
Gerloff C, Friese MA, Mulert C. A clinical and neurobiological case 1994;35:561‑72.
of IgM NMDA receptor antibody associated encephalitis mimicking 71. Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune
bipolar disorder. Psychiatry Res 2013;208:194‑6. disease. Autoimmun Rev 2008;7:209‑13.
53. Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, 72. Ortiz‑Dominguez A, Hernandez ME, Berlanga C, Gutierrez‑Mora D,
Vielhaber S, Kastner A, Skalej M, Jordan W, Schiltz K, Moreno J, Heinze G, Pavon L. Immune variations in bipolar

Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015 235